[Treatment of rosacea with metronidazole internally and externally].
Linda Prinz
Abstract
Linda Prinz
Abstract
Twenty-two patients suffering from rosacea papulosa or rosacea papulo-pustulosa were treated with Metronidazole at a low dosage (125 or 250 mg/d) for 2 to 6 months. According to our observations during a follow-up period of 12 months, this long-term therapy is well-tolerated and early recurrences are rare in comparison to the former short-term therapy with Metronidazole. It may be called an alternative to tetracycline therapy.
OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Twenty-two patients suffering from rosacea papulosa or rosacea papulo-pustulosa were treated with Metronidazole at a low dosage (125 or 250 mg/d) for 2 to 6 months. According to our observations during a follow-up period of 12 months, this long-term therapy is well-tolerated and early recurrences are rare in comparison to the former short-term therapy with Metronidazole. It may be called an alternative to tetracycline therapy.
Key concepts: Rosacea, Metronidazole, Medicine, Dermatology, Tetracycline, Antibiotics, Acne, Microbiology